Embark on our journey in personalised medicines
Discover our latest highlights
September 2024
Leiden Patient Week
We celebrated Leiden Patient Week with inspiring sessions and activities. Highlights include the moving "Who are you working for" story and an engagement CAR-T Game to explore our operations process.
From Paris to London for cancer research
The C2C4C (Country 2 Country 4 cancer) ride was unforgettable from Paris to London, covering over 300 km in 3 days. Each participant carried their personal story with every pedal stroke, forging lasting friendships along the way. Together, our Leiden team put all their efforts into raising funds and awareness for cancer research.
August 2024
Celebrating achievements and inclusion together
"Here Comes the Sun" was an unforgettable event where our Leiden colleagues came together to celebrate their achievements and inclusion.
Important milestone: 2 million safe hours at Leiden
On July 10th, we reached an incredible milestone: 2 million working hours without a recordable case. With approximately 400 people on-site daily, this achievement highlights the effectiveness of our safety protocols and the culture of care and responsibility we’ve fostered.
August 2024
Celebrating achievements and inclusion together
"Here Comes the Sun" was an unforgettable event where our Leiden colleagues came together to celebrate their achievements and inclusion.
Important milestone: 2 million safe hours at Leiden
On July 10th, we reached an incredible milestone: 2 million working hours without a recordable case. With approximately 400 people on-site daily, this achievement highlights the effectiveness of our safety protocols and the culture of care and responsibility we’ve fostered.
June 2024
BMS logo now tops our Cell Therapy Facility
The BMS logo now proudly adorns our Cell Therapy Facility, symbolising our commitment to innovation, excellence, and patient care. A powerful moment reinforcing our presence and identity!
April 2024
Welcoming local stakeholders
BMS Leiden hosted a delegation of stakeholders, including representatives from LUMC, Leiden University, LBSP, and local municipalities. Visitors were impressed by our CAR-T-therapy mission and commitment to patients in Europe. With this visit, we started valuable interactions and collaborations for the future of BMS in Leiden.
First IG] inspection: one step closer to serving our patients from Leiden
BMS underwent its first IG) inspection, focused on QP Certification and oversight of imported Cell Therapy products. While most activities remain under the Utrecht license, Cell Therapy QP activities will move to Leiden. This inspection is a key step toward obtaining Leiden's first MIA license, which applies to the release of imported products.
November 2023
Embracing diversity by implementing PRBGs
As our site grows, we embrace the diversity of our workforce by establishing People and Business Ressource Groups (PBRGs) to drive business results, enhance engagement, and support career development.
After two weeks of voting, we’re excited to announce the core teams for B-NOW, CLIMB, and PRIDE Alliance. These teams, alongside UNITE and OLA, are already working on their charters to represent Leiden and foster inclusivity.
November 2023
Embracing diversity by implementing PRBGs
As our site grows, we embrace the diversity of our workforce by establishing People and Business Ressource Groups (PBRGs) to drive business results, enhance engagement, and support career development.
After two weeks of voting, we’re excited to announce the core teams for B-NOW, CLIMB, and PRIDE Alliance. These teams, alongside UNITE and OLA, are already working on their charters to represent Leiden and foster inclusivity.
September 2023
BMS Leiden’s first Works Council
In June 2023, BMS Leiden Cell Therapy Manufacturing site employees elected members to occupy nine seats in the Works Council. Then, a two-day Works Council training took place on 18 and 19 September to introduce newly elected members to their roles and responsibilities under the Works Council Act. As an outcome of the training, the Council outlined its duties, established priorities, and decided on its working strategy.
Global Patient Week
Leiden proudly participated in Global Patient Week for the second time. We took this time to celebrate patients and their journeys while reflecting on the shared purpose that drives us each day. This week was a meaningful opportunity to honour our mission and reinforce the values that shape our work.
Health Holland and Dutch Ministry of Economic Affairs & Climate Policy on a visit
We had the honour of welcoming a delegation from the Dutch Ministry of Economic Affairs & Climate Policy and representatives from Health Holland. This visit was the perfect opportunity to introduce our new facility and highlight our innovative therapies, including CAR-T Cell Therapy. Our guests were very impressed!
September 2023
BMS Leiden’s first Works Council
In June 2023, BMS Leiden Cell Therapy Manufacturing site employees elected members to occupy nine seats in the Works Council. Then, a two-day Works Council training took place on 18 and 19 September to introduce newly elected members to their roles and responsibilities under the Works Council Act. As an outcome of the training, the Council outlined its duties, established priorities, and decided on its working strategy.
Global Patient Week
Leiden proudly participated in Global Patient Week for the second time. We took this time to celebrate patients and their journeys while reflecting on the shared purpose that drives us each day. This week was a meaningful opportunity to honour our mission and reinforce the values that shape our work.
Health Holland and Dutch Ministry of Economic Affairs & Climate Policy on a visit
We had the honour of welcoming a delegation from the Dutch Ministry of Economic Affairs & Climate Policy and representatives from Health Holland. This visit was the perfect opportunity to introduce our new facility and highlight our innovative therapies, including CAR-T Cell Therapy. Our guests were very impressed!
January 2023
New Year, new faces
New Year, new series of onboardings in our Leiden team! We are thrilled to welcome 18 talented individuals in our growing BMS family, and we look forward to the positive contributions they will make. We are excited to see the innovative ideas that each new employee will bring to the table to reach our main objective to get Cell Therapy closer to European patients.
December 2022
A new onboarding day to end the year in style!
New month, new talent joining our BMS Leiden team. During the December onboarding days, our latest colleagues to join the BMS family in 2022, were warmly welcomed.
December 2022
A new onboarding day to end the year in style!
New month, new talent joining our BMS Leiden team. During the December onboarding days, our latest colleagues to join the BMS family in 2022, were warmly welcomed.
24 November 2022
Construction update
After spending more than 250,000 manhours to date the building of our first European Cell Therapy facility is getting its shape! It has been a pleasure watching the development of the building, from the first pile in October 2021 to where we are now.
November 2022
12 new talents on board!
The BMS family keeps expanding and we were very happy to welcome 12 new members in Leiden during our November onboarding days.
November 2022
12 new talents on board!
The BMS family keeps expanding and we were very happy to welcome 12 new members in Leiden during our November onboarding days.
October 2022
Onboarding day
We are always pleased to welcome new talent and during the month of October no less than nine new faces joined our Leiden team.
16 September 2022
Working meeting ministries
We were honoured to welcome the Ministry of Health, Welfare and Sport and the Ministry of Economic Affairs and Climate Change on the building site of our future CAR-T production centre in the Leiden Bio Science Park.
It was a great opportunity to discuss the business climate in the Netherlands, recruitment and education of the workforce, collaboration with external partners, supply chain and resource management of innovative medicines and certification of CAR-T treatment centres in the Netherlands.
16 September 2022
Working meeting ministries
We were honoured to welcome the Ministry of Health, Welfare and Sport and the Ministry of Economic Affairs and Climate Change on the building site of our future CAR-T production centre in the Leiden Bio Science Park.
It was a great opportunity to discuss the business climate in the Netherlands, recruitment and education of the workforce, collaboration with external partners, supply chain and resource management of innovative medicines and certification of CAR-T treatment centres in the Netherlands.
14 September 2022
TalentOn
Bright Young Minds together! Ann Emmerechts has been shedding the light on the regulatory challenges with novel anti-cancer therapies at the @European Commission @EU TalentOn, that took place from 14 to 17 September in Leiden.
1 September 2022
Final beam of steel placed on the Cell Therapy Facility
It’s done! The last beam of steel was lifted onto our first European Cell Therapy manufacturing facility in Leiden, topping off our future building and completing the structural steelwork.
Bristol Myers Squibb Executive Director, Global Engineering Anthony Cable and Benelux General Manager Sally Ann McNab joined us during the traditional topping off ceremony at the Leiden Bio Science Park. We look forward to this facility bringing cell therapy closer to patients in Europe.
A big round of applause for everyone who made this happen!
1 September 2022
Final beam of steel placed on the Cell Therapy Facility
It’s done! The last beam of steel was lifted onto our first European Cell Therapy manufacturing facility in Leiden, topping off our future building and completing the structural steelwork.
Bristol Myers Squibb Executive Director, Global Engineering Anthony Cable and Benelux General Manager Sally Ann McNab joined us during the traditional topping off ceremony at the Leiden Bio Science Park. We look forward to this facility bringing cell therapy closer to patients in Europe.
A big round of applause for everyone who made this happen!
August 2022
The Leiden family keeps growing!
Our Leiden team expanded in August and September with the addition of many new faces. In total, 30 new talents joined the team.
27 July 2022
Almost a roof above our heads
How exciting it is to see the evolution of our first European cell therapy production site in Leiden. Here you see the progress of the building, with the last pieces of foundation and the first concrete on the roof.
27 July 2022
Almost a roof above our heads
How exciting it is to see the evolution of our first European cell therapy production site in Leiden. Here you see the progress of the building, with the last pieces of foundation and the first concrete on the roof.
July 2022
Onboarding day
More new faces at Bristol Myers Squibb in Leiden! This month, we’ve welcomed and onboarded no less than 8 new colleagues. Such a joy to see our Leiden team growing and growing!
9 July 2022
Training for C2C4C in Leiden
Our Benelux Country2Country4Cancer team is in full training mode to cycle in September to raise awareness for cancer research and European cancer organisations that are members of the Union for International Cancer Control (UICC).
Last weekend, the team did a tour in the region of Leiden. The cherry on the cake was a visit to our construction site in the Leiden Bio Science Park, where we are building our first European Cell therapy production facility to bring CAR-T closer to European patients. Sally Ann McNab and Arjen Schippers who cycled with the team were proud to show the excellent progress of the construction works.
9 July 2022
Training for C2C4C in Leiden
Our Benelux Country2Country4Cancer team is in full training mode to cycle in September to raise awareness for cancer research and European cancer organisations that are members of the Union for International Cancer Control (UICC).
Last weekend, the team did a tour in the region of Leiden. The cherry on the cake was a visit to our construction site in the Leiden Bio Science Park, where we are building our first European Cell therapy production facility to bring CAR-T closer to European patients. Sally Ann McNab and Arjen Schippers who cycled with the team were proud to show the excellent progress of the construction works.
30 June 2022
Starting to look like a building
Construction work on our first European production facility for CAR-T cell therapy is progressing rapidly!
June 2022
Onboarding day
Welcome to all new colleagues! They are now part of an exciting journey to bring CAR-T cell therapy closer to European patients.
June 2022
Onboarding day
Welcome to all new colleagues! They are now part of an exciting journey to bring CAR-T cell therapy closer to European patients.
17 June 2022
Family day @ Leiden
On the occasion of 'Dag van de Bouw' in the Netherlands (June 18th), we invited everybody working on getting our first European Cell therapy facility ready to bring their families to Leiden. On the agenda: a guided tour of the Bristol Myers Squibb construction site at the Leiden Bio Science Park.
Showing our loved ones how and where we will bring these personalized therapies closer to European patients was a fantastic experience. They could feel our proudness when we showed how we are contributing to the future of medicine.
30 May 2022
BMS speaks at the Global Impact in Health Symposium in Leiden
Anne Kerber, Senior VP and Head of Cell Therapy Development at BMS, spoke at the Symposium about the importance of equity and diversity in clinical trials to deliver better science and outcomes for patients.
Learn more about why health equity is important and how BMS is taking action.
30 May 2022
BMS speaks at the Global Impact in Health Symposium in Leiden
Anne Kerber, Senior VP and Head of Cell Therapy Development at BMS, spoke at the Symposium about the importance of equity and diversity in clinical trials to deliver better science and outcomes for patients.
Learn more about why health equity is important and how BMS is taking action.
May 2022
13 new colleagues joined!
We had the pleasure to welcome more new colleagues in Leiden, where we are building our first European Cell therapy production site.
13 May 2022
Progress with the steelwork
Excellent progress has been made with the steelwork. The building is shaping up nicely and all construction works are progressing according to plan. Stay tuned!
13 May 2022
Progress with the steelwork
Excellent progress has been made with the steelwork. The building is shaping up nicely and all construction works are progressing according to plan. Stay tuned!
2 May 2022
Interview with Arjen Schippers and InnovationQuarter
Read the interview with Arjen Schippers, Senior Director and Program Head of Europe Cell Therapy Facility at Bristol Myers Squibb about what he has worked on over the last year with support from InnovationQuarter and what can be expected in the coming months.
Read the full article by clicking on this link.
March 2022
9 more colleagues joined us at Leiden
An extra 9 colleagues have chosen a career where their work will change the lives of patients. We are still looking for many profiles, if ground-breaking work drives you, join us in helping to bring cancer-fighting CAR-T Cell Therapies to patients across Europe.
March 2022
9 more colleagues joined us at Leiden
An extra 9 colleagues have chosen a career where their work will change the lives of patients. We are still looking for many profiles, if ground-breaking work drives you, join us in helping to bring cancer-fighting CAR-T Cell Therapies to patients across Europe.
15 February 2022
Virtual Career Event BCF Career
Arjan Schippers welcomed many interested potential co-workers for the new CAR-T Cell Therapy facility in Leiden. He talked about how you can create a meaningful career and bring new hope to cancer patients.
February 2022
First steel is going up
It's full steam ahead on our Leiden construction site. The first steel nearly arrived, and is up already. So far, the construction of our very first European cell therapy facility in Leiden is progressing as planned. Stay tuned!
February 2022
First steel is going up
It's full steam ahead on our Leiden construction site. The first steel nearly arrived, and is up already. So far, the construction of our very first European cell therapy facility in Leiden is progressing as planned. Stay tuned!
January 2022
Foundation works completed
In January, we lay the foundation of the building. It will essentially be standing on 591 piles driven to a depth of 30 meters through soil, then sea water to reach deep compacted sand. We have successfully installed almost all 591 piles and completed on track this month.
October 2021
BCF Career Event in Utrecht
We are present at the BCF Career Event in Utrecht, the largest science job fair. What an energy we felt to meet again in-person and to tell how we transform the lives of millions of people through innovation and science.
October 2021
BCF Career Event in Utrecht
We are present at the BCF Career Event in Utrecht, the largest science job fair. What an energy we felt to meet again in-person and to tell how we transform the lives of millions of people through innovation and science.
28 October 2021
Bristol Myers Squibb starts construction of its European therapy facility and marks it with a Celebration Event
Bristol Myers Squibb celebrated the start of the construction of its first European cell therapy facility at the Leiden Bio Science Park in the Netherlands.
The celebration event was concluded with Arjen Schippers, Program Head of Europe Cell Therapy Facility, raising the flag on the new site: “Like the first man on the moon, I am really honoured to plant the BMS flag in Europe. Let this be the symbol of our commitment to discover, develop and deliver innovative medicines to help patients prevail over serious diseases.”
22 April 2021
Bristol Myers Squibb chooses Leiden Bio Science Park as the European site for a new CAR-T cell therapy facility
By building this production facility, BMS is investing in the expansion of its global network to bring cell therapy closer to the European patient. In doing so, the organisation is expanding its capacity to treat patients.
22 April 2021
Bristol Myers Squibb chooses Leiden Bio Science Park as the European site for a new CAR-T cell therapy facility
By building this production facility, BMS is investing in the expansion of its global network to bring cell therapy closer to the European patient. In doing so, the organisation is expanding its capacity to treat patients.
2019
Bristol Myers Squibb acquires Celgene
Bristol Myers Squibb and Celgene come together to create a leading biopharma company positioned to address the needs of patients with serious diseases.
2017
FDA approves First CAR-T therapy
The first CAR-T therapy is approved in 2017 for the treatment of young adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia.
2017
FDA approves First CAR-T therapy
The first CAR-T therapy is approved in 2017 for the treatment of young adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia.